Legend Biotech

Legend Biotech company information, Employees & Contact Information

Explore related pages

Related company profiles:

Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.

Company Details

Employees
2.14K
Address
2101 Cottontail Lane, Somerset,new Jersey 08873,united States
Phone
1.732.317.5050
Email
in****@****ech.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Somerset, New Jersey
Looking for a particular Legend Biotech employee's phone or email?

Legend Biotech Questions

News

Legend Biotech Appoints Carlos Santos as Chief Financial Officer - Yahoo Finance

Legend Biotech Appoints Carlos Santos as Chief Financial Officer Yahoo Finance

Global Cell Therapy Leader Legend Biotech to Present at Morgan Stanley Healthcare Conference in NY - Stock Titan

Global Cell Therapy Leader Legend Biotech to Present at Morgan Stanley Healthcare Conference in NY Stock Titan

Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results - FinancialContent

Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results FinancialContent

Legend Biotech CEO to Present Company Updates at 43rd Annual J.P. Morgan Healthcare Conference - Quiver Quantitative

Legend Biotech CEO to Present Company Updates at 43rd Annual J.P. Morgan Healthcare Conference Quiver Quantitative

Former AstraZeneca US Oncology CFO Carlos Santos Joins Cell Therapy Leader Legend Biotech as Finance Chief - Stock Titan

Former AstraZeneca US Oncology CFO Carlos Santos Joins Cell Therapy Leader Legend Biotech as Finance Chief Stock Titan

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference - Yahoo Finance

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference Yahoo Finance

Legend Biotech Announces Closing of License Transaction for Certain CAR-T Therapies Targeting DLL3 - Business Wire

Legend Biotech Announces Closing of License Transaction for Certain CAR-T Therapies Targeting DLL3 Business Wire

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights - Stock Titan

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights Stock Titan

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights - Yahoo Finance

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights Yahoo Finance

Legend Biotech to Host Conference Call for Q2 2025 Results on August 11, 2025 - Quiver Quantitative

Legend Biotech to Host Conference Call for Q2 2025 Results on August 11, 2025 Quiver Quantitative

Legend Biotech Announces Participation in Upcoming Investor Conference - Business Wire

Legend Biotech Announces Participation in Upcoming Investor Conference Business Wire

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights - Yahoo Finance

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights Yahoo Finance

Legend Biotech Reports $963 Million in CARVYKTI® Sales for 2024 and Initiates Commercial Production at Novartis Facility - Quiver Quantitative

Legend Biotech Reports $963 Million in CARVYKTI® Sales for 2024 and Initiates Commercial Production at Novartis Facility Quiver Quantitative

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia - Yahoo Finance

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia Yahoo Finance

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT - Yahoo Finance

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT Yahoo Finance

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report - Business Wire

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report Business Wire

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia - citybiz

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia citybiz

EX-99.1 - SEC.gov

EX-99.1 SEC.gov

Legend Biotech Announces FDA Clinical Hold of its Phase 1 Clinical Trial for LB1901 - Business Wire

Legend Biotech Announces FDA Clinical Hold of its Phase 1 Clinical Trial for LB1901 Business Wire

Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights - Business Wire

Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights Business Wire

Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights - Stock Titan

Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights Stock Titan

Janssen and Legend Biotech’s Carvykti to be Put in Front of FDA AdComm Regarding Multiple Myeloma Expanded Use BLA - CGTLive®

Janssen and Legend Biotech’s Carvykti to be Put in Front of FDA AdComm Regarding Multiple Myeloma Expanded Use BLA CGTLive®

Legend Biotech Announces Notification of Delinquency from The Nasdaq Stock Market LLC - Business Wire

Legend Biotech Announces Notification of Delinquency from The Nasdaq Stock Market LLC Business Wire

Legend Biotech Reports Third Quarter 2020 Financial Results - Business Wire

Legend Biotech Reports Third Quarter 2020 Financial Results Business Wire

Legend Biotech Appoints Mythili Koneru, M.D., Ph.D. as Chief Medical Officer - citybiz

Legend Biotech Appoints Mythili Koneru, M.D., Ph.D. as Chief Medical Officer citybiz

Legend Biotech to Participate in the 41st Annual JP Morgan Healthcare Conference - FinancialContent

Legend Biotech to Participate in the 41st Annual JP Morgan Healthcare Conference FinancialContent

Legend Biotech Appoints Lori Macomber as Chief Financial Officer - citybiz

Legend Biotech Appoints Lori Macomber as Chief Financial Officer citybiz

Legend Biotech to Host 2022 R&D Day on Monday, October 3, 2022 | PRN_FinancialWrapper | PR Newswire - FinancialContent

Legend Biotech to Host 2022 R&D Day on Monday, October 3, 2022 | PRN_FinancialWrapper | PR Newswire FinancialContent

Legend Biotech Appoints Ying Huang as Interim CEO - citybiz

Legend Biotech Appoints Ying Huang as Interim CEO citybiz

Legend Biotech Closes Initial Public Offering Raising Big Money - geneonline.com

Legend Biotech Closes Initial Public Offering Raising Big Money geneonline.com

Trinity, St. James’s and Legend Biotech: strategic collaboration explores solid tumours - Trinity College Dublin

Trinity, St. James’s and Legend Biotech: strategic collaboration explores solid tumours Trinity College Dublin

CARVYKTI ® (ciltacabtagene autoleucel) Granted Conditional Approval by the European Commission for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma - Via TT

CARVYKTI ® (ciltacabtagene autoleucel) Granted Conditional Approval by the European Commission for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma Via TT

Legend Biotech Ireland, Ltd. celebrates the official opening of its European headquarters in Dublin - IDA Ireland

Legend Biotech Ireland, Ltd. celebrates the official opening of its European headquarters in Dublin IDA Ireland

Top Legend Biotech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant